 | Review waiting, please be patient.
This may take 3 months or more, since drafts are reviewed in no specific order. There are 2,834 pending submissions waiting for review.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Reviewer tools
|
| Submission declined on 6 February 2024 by
Liance (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. This draft's references do not show that the subject
qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are:
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
This draft has been resubmitted and is currently awaiting re-review. |  |
| Submission declined on 6 June 2023 by
Drmies (
talk). This draft's references do not show that the subject
qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are: Declined by
Drmies 13 months ago.
| |
| Submission declined on 5 December 2022 by
Tom (LT) (
talk). This draft's references do not show that the subject
qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are: Declined by
Tom (LT) 19 months ago.
| |
| Submission declined on 2 September 2022 by
The Most Comfortable Chair (
talk). This submission does not appear to be written in
the formal tone expected of an encyclopedia article. Entries should be written from a
neutral point of view, and should refer to a range of
independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid
peacock terms that promote the subject. Declined by
The Most Comfortable Chair 22 months ago. | |
Comment: Please remove all external links from the body of this draft; see
WP:ELBODY.
jlwoodwa (
talk) 00:42, 4 June 2024 (UTC)
- Comment: Needs to concretely show, using sources not affiliated with this organisation, that it is independently notable.
Tom (LT) (
talk) 10:19, 5 December 2022 (UTC)
Outcome Measures in Rheumatology (OMERACT) is an international initiative aimed at improving outcome measurement in rheumatology. Established in 1992, OMERACT organizes biennial consensus conferences to develop and refine core sets of measures for rheumatologic conditions, with an emphasis on data-driven recommendations. [1].
Founding and Organization:
OMERACT was initiated by Dr. Peter Tugwell and Dr. Maarten Boers, who observed discrepancies in outcome measures between European and North American rheumatoid arthritis clinical trials. The first conference was held in Maastricht, the Netherlands, in 1992. The initiative was originally chaired by 4 member executive committee consisting of Dr. Maarten Boers, Dr. Peter Brooks, Dr. Peter Tugwell, and Dr. Vibeke Strand [2].
Mission and Activities:
OMERACT's mission is to improve endpoint outcome measurement through an iterative, data-driven process. The key activities include:
- Organizing consensus conferences every two years [3].
- Engaging stakeholders including patients since 2002 [4].
- Developing and updating core sets of measures for rheumatologic conditions [1].
Impact and Achievements:
OMERACT has achieved consensus on Core Outcome Sets for conditions such as rheumatoid arthritis, osteoarthritis, and osteoporosis [5]. The measures endorsed by OMERACT are widely adopted in clinical trials and systematic reviews, contributing to standardization in the field [2]. OMERACT’s methodology has been emulated in other medical fields and international collaborations [6] [7] [8] [9] [10] [11] [12] [13].
Governance and Funding:
OMERACT operates as a registered not-for-profit organization in Canada [14]
- ^ a b Tugwell, Peter; Boers, Maarten; Brooks, Peter; Simon, Lee; Strand, Vibeke; Idzerda, Leanne (2007-11-26). "OMERACT: An international initiative to improve outcome measurement in rheumatology". Trials. 8 (1): 38. doi: 10.1186/1745-6215-8-38. ISSN 1745-6215. PMC 2169260. PMID 18039364.
- ^ a b "Rheumatology's Divergent Thinkers". The Rheumatologist. Retrieved 2024-06-03.
- ^ "OMERACT continues to set standards on research outcomes, enhancing the patient voice". www.mdedge.com. August 30, 2022. Retrieved 2024-06-03.
- ^ de Wit, Maarten; Kirwan, John R.; Tugwell, Peter; Beaton, Dorcas; Boers, Maarten; Brooks, Peter; Collins, Sarah; Conaghan, Philip G.; D'Agostino, Maria-Antonietta; Hofstetter, Cathie; Hughes, Rod; Leong, Amye; Lyddiatt, Ann; March, Lyn; May, James (April 2017). "Successful Stepwise Development of Patient Research Partnership: 14 Years' Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT)". The Patient. 10 (2): 141–152. doi: 10.1007/s40271-016-0198-4. ISSN 1178-1661. PMC 5362656. PMID 27704486.
- ^ Firestein, Gary S. (2021). Firestein & Kelley's textbook of rheumatology. Ralph C. Budd, Sherine E. Gabriel, Gary A. Koretzky, Iain B. McInnes, James R. O'Dell (11. ed.). Philadelphia, PA: Elsevier. ISBN 978-0-323-63920-0.
- ^ "COMET Initiative | Collaborations". comet-initiative.org. Retrieved 2024-06-03.
- ^ "About the initiative • COSMIN". COSMIN. Retrieved 2024-06-03.
- ^ "Research Methods". www.c3outcomes.org. Retrieved 2024-06-03.
- ^ "Related Organizations". GRAPPA Network. Retrieved 2024-06-03.
- ^ "About – SONG". Retrieved 2024-06-03.
- ^ "International Dermatology Outcome Measures - Collaborators". www.dermoutcomes.org. Retrieved 2024-06-03.
- ^ Research, Center for Drug Evaluation and (2024-04-29). "Scientific Public Private Partnerships and Consortia". FDA.
- ^ "News - ASAS". www.asas-group.org. 2020-07-09. Retrieved 2024-06-03.
- ^ "Federal Corporation Information - 433818-9". Innovation, Science and Economic Development Canada. Retrieved June 3, 2024.
- Pending AfC submissions
- AfC pending submissions by age/6 weeks ago
- AfC submissions by date/03 June 2024
- AfC submissions by date/06 February 2024
- AfC submissions by date/05 March 2023
- AfC submissions by date/13 September 2022
- AfC submissions by date/18 August 2022
- Draft articles on medicine and health
- Draft articles on technology
- AfC submissions on organisations existing today